Article

The 12-month prevalence and risk factors for major depressive episode in Finland: representative sample of 5993 adults.

National Public Health Institute, Department of Mental Health and Alcohol Research, Helsinki, Finland.
Acta Psychiatrica Scandinavica (Impact Factor: 4.86). 10/2000; 102(3):178-84. DOI: 10.1034/j.1600-0447.2000.102003178.x
Source: PubMed

ABSTRACT This study reports the 12-month prevalence of major depressive episode and its risk factors in a representative nationwide sample.
A random sample of non-institutionalized Finnish individuals aged 15-75 years (N = 5993) was interviewed in 1996. Major depressive episode during the last 12 months was assessed using the Short Form of the University of Michigan version of the Composite International Diagnostic Interview (the UM-CIDI Short Form).
The population prevalence of major depressive episode was 9.3% [95% CI 8.5,10.0], and the age-adjusted prevalences for females and males were 10.9% [95% CI 9.7,12.0] and 7.2 [95% CI 6.2,8.2], respectively. In logistic regression analyses the factors associated with major depressive episode after adjustment for age were urban residency, smoking, alcohol intoxication and chronic medical conditions. In addition, being single and obese were found to be risk factors for males.
The female to male risk ratio for major depressive episode was smaller than in many previous studies. The sex-specific risk factor associations warrant further investigation into sex differences in depression.

0 Bookmarks
 · 
46 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Interpersonal psychotherapy (IPT) has shown efficacy in randomized controlled trials. No reports exist on IPT for depressed patients with severe psychiatric comorbidities in public outpatient clinics. This pilot feasibility study assessed preliminary effectiveness and patient satisfaction with IPT for depressed patients with psychiatric comorbidities in municipal outpatient care in Turku, Finland. Because lengthy treatment strains mental healthcare resources, this trial also assessed the potential for IPT, a time-limited treatment, to discharge patients successfully. Seven clinicians in two municipal clinics were briefly trained to deliver IPT, while clinicians in two other clinics provided treatment as usual (TAU). Twenty-six patients with moderate to severe major depressive disorder received IPT for 16 weeks, and a control group (n = 20) received TAU. Seventy-six percent of patients had concurrent anxiety disorders, 73% personality disorders and 20% alcohol dependence. As 61% of patients received concurrent pharmacotherapy, the study lacked statistical power to find outcome differences between treatment groups. Depressive symptoms, social functioning and self-perceived health improved notably in both groups. The mean Hamilton Depression Rating Scale (HAMD) score decreased from 20 to 10. Using HAMD ≤ 7 as a cutoff, 28.3% of patients achieved remission. Patients receiving IPT reported significantly greater satisfaction with their treatment and were more often able to terminate treatment after 16 sessions. Both treatments were effective in this small, highly comorbid sample. Conducting IPT appeared feasible in municipal outpatient clinics and offered some advantages over TAU. It was possible to train staff quickly. These results warrant a further, larger randomized trial.
    Nordic journal of psychiatry 03/2011; 65(6):427-32. · 0.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: A two-year action project to establish the indicators for mental health monitoring in Europe started in 1999 under the sponsorship of the EC Health Monitoring Programme. Aims: This paper reports the results of a pilot survey conducted to test the feasibility of the set of survey indicators proposed. The test phase of the implementation of the set of mental health indicators involved five of the Active Partners (France, Germany, Greece, Finland, and Norway) of the Mental Health Indicators Project. Method: The sample consists of 2059 subjects, 923 men (44.8%) and 1136 (55.2%) women. The number of subjects interviewed in each country ranged between 378 (Norway) and 441 (France). Results: The coverage of collected data was good. However, telephone interviews did not appear to be the method-of-choice for conducting surveys regarding mental health indicators in the future. The prevalence figures of major depression and risk of having a problem with alcohol are in agreement with the major European studies. Conclusions: The set of indicators could be easily incorporated into general health surveys, as the interviews conducted were not time-consuming. The results supported the view that the citizens interviewed have found the survey easily acceptable. Declaration of interest: None.
    07/2009; 16(3):401-413.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: As patients with Parkinson's disease (PD) are at high risk for comorbid depression, it is hypothesized that these two diseases are sharing common pathogenic pathways. Using regional homogeneity (ReHo) and functional connectivity approaches, we characterized human regional brain activity at resting state to examine specific brain networks in patients with PD and those with PD and depression (PDD). This study comprised 41 PD human patients and 25 normal human subjects. The patients completed the Hamilton Depression Rating Scale and were further divided into two groups: patients with depressive symptoms and non-depressed PD patients (nD-PD). Compared with the non-depressed patients, those with depressive symptoms exhibited significantly increased regional activity in the left middle frontal gyrus and right inferior frontal gyrus, and decreased ReHo in the left amygdala and bilateral lingual gyrus. Brain network connectivity analysis revealed decreased functional connectivity within the prefrontal-limbic system and increased functional connectivity in the prefrontal cortex and lingual gyrus in PDD compared with the nD-PD group. In summary, the findings showed regional brain activity alterations and disruption of the mood regulation network in PDD patients. The pathogenesis of PDD may be attributed to abnormal neural activity in multiple brain regions.
    PLoS ONE 01/2014; 9(1):e84705. · 3.53 Impact Factor